APSR2026-628

Yes
Late-Breaking
Submitted
Poster Presentation
 
AP11-009
P51
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1220656-46904-AP11-009_APSR_2026_Poster_Shih-Hao Chung_433578.pdf
Format: PDF Only
09. Asthma
8

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Shih-Hao Chung * MacKay Memorial Hospital Tamshui Branch Division of Chest, Department of Internal Medicine New Taipei City Taiwan
Ching-Lung Liu - MacKay Memorial Hospital Tamshui Branch Division of Chest, Department of Internal Medicine New Taipei City Taiwan
Chang-Yi Lin - MacKay Memorial Hospital Tamshui Branch Division of Chest, Department of Internal Medicine New Taipei City Taiwan
Chieh-Jen Wang - MacKay Memorial Hospital Tamshui Branch Division of Chest, Department of Internal Medicine New Taipei City Taiwan
Wen-Kuei Chang - MacKay Memorial Hospital Tamshui Branch Division of Chest, Department of Internal Medicine New Taipei City Taiwan
Yu-Chung Kung - MacKay Memorial Hospital Tamshui Branch Department of Critical Care Medicine New Taipei City Taiwan
Wen-Chi Chao - MacKay Memorial Hospital Tamshui Branch Department of Critical Care Medicine New Taipei City Taiwan
Yen-Hsiang Tang - MacKay Memorial Hospital Tamshui Branch Department of Critical Care Medicine New Taipei City Taiwan
 
 
 
 
 
 
 
Presenting Author Details
Shih-Hao
Chung
jason37945@gmail.com
+886933750943
31-40
Taiwan
Original Research
Comparison of ventilatory parameters in refractory status asthmaticus and viral ARDS under VV-ECMO: a single-center experience
Maximum 25 words
Abstract Content
Venovenous extracorporeal membrane oxygenation (VV-ECMO) is an established rescue therapy for refractory respiratory failure. We compared ventilatory parameters and clinical outcomes between patients with status asthmaticus and viral pneumonia–associated acute respiratory distress syndrome (ARDS) receiving ECMO support.
We retrospectively reviewed six patients who received VV-ECMO at a single center between October 2022 and August 2024: three with refractory status asthmaticus (aged 21–55 years) and three with viral ARDS (aged 47–59 years; two influenza A, one COVID-19). Respiratory rate (RR), peak inspiratory pressure (PIP), and airway resistance were assessed before and after ECMO cannulation.
Prior to ECMO initiation, the asthma group had more severe hypercapnia (PaCO₂ 91–111 vs. 47–71 mmHg) and acidosis (pH 7.03–7.26 vs. 7.14–7.21), with higher airway resistance (50–98 vs. 16–23 cmH₂O/L/s) and PIP (44–57 vs. 36–46 cmH₂O), but lower RR (12–24 vs. 24–30 breaths/min) compared to the ARDS group. Following ECMO cannulation, asthma patients showed rapid correction of PaCO₂ (26–44 mmHg) and pH (7.33–7.50), with decreased resistance (33–45 cmH₂O/L/s), whereas ARDS patients had modest improvement (pH 7.18–7.32; PaCO₂ 32–46 mmHg). All asthma patients survived to discharge. In the ARDS group, two died before decannulation; the survivor required prolonged ventilation and ICU stay.
Status asthmaticus and viral ARDS exhibit distinct ventilatory profiles, particularly in airway resistance, and different responses to VV-ECMO. Despite more severe initial derangements, asthma patients improved rapidly with better outcomes, whereas ARDS patients showed limited response and poorer survival. Etiology and airway mechanics appear to be key determinants of ECMO responsiveness.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
status asthmaticus, mechanical ventilation, venovenous extracorporeal membrane oxygenation
maximum 3 keywords and no abbreviations, separated by commas
The authors thank all ICU staff involved in patient care. No funding was received, and no conflicts of interest are declared.
279